The presence of the antigliadin antibodies in autoimmune thyroid diseases

Hepato-gastroenterology, 50 Suppl 2, cclxxix-cclxxx

Source

Abstract

Aims

To investigate the presence of the antigliadin antibodies in the patients with Graves' disease and Hashimoto's thyroiditis.

METHODOLOGY: Four hundred patients with autoimmune thyroid disease (280 Graves' disease and 120 Hashimoto's thyroiditis ) were included in the study. The patients with celiac sprue patients were excluded. For the diagnosis of autoimmune thyroiditis, blood levels of thyrotropin (TSH), free thyroxine (FT4), and the titration of thyroid autoantibodies (TgAb and TmAb) were measured, and the thyroid gland was ultrasonographycally evaluated. After the diagnosis of autoimmune thyroid disease was established, the titration of antigliadin antibodies (Ig A and B) were routinely detected.

Results

Twenty two patients (5.5 per cent) with autoimmune thyroiditis had positive antigliadin antibodies. Polyglandular endocrine syndrome was diagnosed in most of these patients.

Conclusions

We claim that polyglandular endocrine syndrome is the commonest cause of positivity of antigliadin antibodies in the patients with autoimmune thyroid disease.

Topics

antigliadin antibodies autoimmune thyroid disease Graves Hashimoto, celiac disease autoimmune thyroiditis antigliadin antibody prevalence, Graves disease Hashimoto thyroiditis gluten sensitivity antibodies, polyglandular endocrine syndrome antigliadin antibodies thyroid, Akcay antigliadin antibodies autoimmune thyroid disease, autoimmune thyroiditis celiac disease association screening, thyroid autoantibodies TgAb TmAb antigliadin IgA IgB, gluten sensitivity autoimmune thyroid disease polyglandular syndrome, Hashimoto thyroiditis celiac sprue antibody screening, autoimmune overlap thyroid disease antigliadin antibody prevalence 5.5 percent

Cite this article

Akçay, M. N., & Akçay, G. (2003). The presence of the antigliadin antibodies in autoimmune thyroid diseases. *Hepato-gastroenterology*, *50 Suppl 2*, cclxxix-cclxxx.